Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients
S. Taddei et al., Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients, CIRCULATION, 100(13), 1999, pp. 1400-1405
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
dBackground-In essential hypertension, endothelium-dependent vasodilation i
s impaired because of reduced nitric oxide (NO) availability, which is main
ly caused by oxidative stress. The present study was designed to identify t
he mechanism(s) responsible for NO-independent vasodilation to bradykinin i
n patients with essential hypertension.
Methods and Results-In 16 healthy subjects (49.5+/-5.8 years; 118.6+/-3.5/7
8.9+/-2.9 mm Hg) and 16 patients with essential hypertension (47.9+/-4.8 ye
ars; 154.6+/-4.5/102.9+/-3.2 mm Hg), we measured modifications in forearm b
lood now (strain-gauge plethysmography) during intrabrachial infusion of br
adykinin (5, 15, or 50 ng/100 mL of forearm tissue per minute) in the prese
nce of saline, N-omega-monomethyl-L-arginine (L-NMMA; used to inhibit NO sy
nthase; 100 mu g/100 mL of forearm tissue per minute), and ouabain (to bloc
k Na+K+/ATPase and prevent hyperpolarization; 0.7 mu g/100 mL of forearm ti
ssue per minute). In healthy subjects, vasodilatation to bradykinin was sig
nificantly blunted by L-NMMA and unaffected by ouabain. In hypertensive pat
ients, vasodilatation to bradykinin was not modified by L-NMMA, but it was
significantly reduced by ouabain. In an adjunctive group of 8 hypertensive
patients (49.9+/-3.8 years; 155.9+/-5.5/103.7+/-3.9 mm Hg), the response to
bradykinin was repeated during the administration of intrabrachial vitamin
C (a scavenger for oxygen free radicals; s mg/100 mL of forearm tissue per
minute). In these patients, L-NMMA-induced inhibition of vasodilation to b
radykinin was restored, and ouabain was no longer effective. In a final gro
up of 6 normotensive controls (45.9+/-4.1 years; 115.1+/-2.9/79.3+/-2.1 mm
Hg), vasodilation to bradykinin residual to L-NMMA blockade was further inh
ibited by simultaneous ouabain infusion.
Conclusions-Vasodilation to bradykinin is impaired in essential hypertensiv
e patients because of an NO-system alteration caused by oxidative stress, a
nd it is mediated by an alternative pathway, possibly involving endothelium
-dependent hyperpolarization.